SCHEMBL8334941

SCHEMBL8334941

CCCC(CCCC(N=S(=O)=O)C(C(=O)NC(=S)NC)c1ccccc1)OC

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ HTT P42858 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ GPR88 Q9GZN0 4/20 0.32
▸ CTSK P43235 2/20 0.31
▸ NAAA Q02083 2/20 0.31
▸ POLB P06746 1/20 0.31
▸ KCNQ2 O43526 1/20 0.31
▸ NPSR1 Q6W5P4 2/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ ALOX12 P18054 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8340676 0.93 KMT2A (0.37) KMT2AMEN1KDM4EHTTSMN1; SMN2
SCHEMBL8336354 0.87 KMT2A (0.36) KMT2AMEN1KDM4EHTTSMN1; SMN2
SCHEMBL8333962 0.78 KDM4E (0.37) KMT2AMEN1KDM4EHTTSMN1; SMN2
SCHEMBL8340568 0.77 KDM4E (0.36) KMT2AMEN1KDM4EHTTSMN1; SMN2
SCHEMBL8338439 0.71 KDM4E (0.32) KMT2AMEN1KDM4EHTTSMN1; SMN2
SCHEMBL8335606 0.68 CTSL (0.33) KMT2AMEN1KDM4EHTTSMN1; SMN2
SCHEMBL8864333 0.67 — —
SCHEMBL8864415 0.66 SLC6A2 (0.32) —
SCHEMBL8865047 0.66 — —
SCHEMBL2605850 0.64 MEN1 (0.47) KMT2AMEN1KDM4EHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977177-A Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-02 — — US disclosed
US-5880155-A TREATMENT OF CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-03-09 — — US disclosed
Send feedback